[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_82":83},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":27,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":-5,"_44":-5,"_45":46,"_47":-5,"_48":-5,"_49":50,"_51":52,"_53":54,"_55":56,"_57":56,"_58":-5,"_59":40,"_60":61},"id","da7auet3r757rj700z71jgpj8","revision",1,"title","BRIGHT MINDS BIOSCIENCES INC. 提交 6-K 文件","originalTitle","6-K - BRIGHT MINDS BIOSCIENCES INC. (0001827401) (Filer)","summary","BRIGHT MINDS BIOSCIENCES INC. 提交 6-K 文件，披露公司投票结果。文件包含公司财务与治理信息，未提及具体产品或技术细节。该文件已纳入公司注册声明。","reason","source",{"_11":72,"_73":74,"_75":76,"_77":56,"_78":79,"_80":81},"links",{"_69":70,"_61":71},"publishedAt","2026-10-02T21:14:23.000Z","discoveredAt","2026-10-04T22:50:09.321Z","timelineAt","category","tip","tags",[67,68],"stockSymbols",[66],"score",20,"selected",false,"channel","news","story","x","readingMode","full","author","language","body",{"_62":-5,"_61":63,"_64":-5,"_65":40},"outline",[],"relatedStories",[],"indexable",true,"markdownAvailable","group","hasTranslation","bodyLanguage","original","zh","

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File No. 001-40997

BRIGHT MINDS BIOSCIENCES INC.
(Translation of registrant's name into English)

\n \n \n \n \n

400 N Aberdeen St Suite 900
Chicago, IL 60642
(U.S. Corporate headquarters)

1122 Mainland St #228
Vancouver, BC V6B 5L1
(Canadian Corporate headquarters)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F [ ] Form 40-F [ X ]

INCORPORATION BY REFERENCE

Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K are incorporated by reference into our (i) registration statement on Form F-3 (File No. 333-284694) filed on February 5, 2025, and (ii) registration statement on Form F-3 (File No. 333-289851) filed on August 26, 2025.

SUBMITTED HEREWITH

\n \n \n \n \n \n \n \n \n

Exhibits
99.1	Report of Voting Results

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BRIGHT MINDS BIOSCIENCES INC.

\"Ryan Cheung\"

Ryan Cheung
Chief Financial Officer

Date: October 2, 2026

","zhKind","complete","DRUG","政策与监管","退市","aihot","/items/da7auet3r757rj700z71jgpj8","https://www.sec.gov/Archives/edgar/data/1827401/000106299326005170/0001062993-26-005170-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1791417600&sig=18cddd50281c55e6","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1791417600&sig=6c66a0408e1695ad 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1791417600&sig=11363acd4f484981 96w","changelogVersion","2026-10-01T08:00"]